Compliance Checker
Ensure your promotional medical materials are MLR-ready
Analyse medical claims against 10 national and international pharma codes of practice
Incorporate social media guidelines in the analysis
Provide instant feedback on compliance issues
beta-0.6.2
Compliance
Compliance Checker
This will clear all data from your current session.
Do you wish to proceed?
Last updated August 2024. This tool uses AI. Please check for mistakes. Disclaimer
How the Tool Works
The Compliance Checker uses AI to analyse promotional claims against key clauses of a number of national and international pharma codes of practices - including social media guidelines. Here's a breakdown of how the tool processes and evaluates your medical claims:
Natural Language Processing
Our AI uses NLP techniques to understand the context and meaning of your promotional claim. It breaks down the claim into its constituent parts, identifying key phrases, product names, and descriptive elements.
Contextual Interpretation
The AI considers the context of the claim, including any qualifications or supporting information provided. It's designed to understand nuances in language that might affect compliance.
Pattern Recognition
The AI has been trained on a large dataset of compliant and non-compliant claims. It uses this training to recognise patterns that are typically associated with Code compliance or potential violations.
Confidence Scoring
For each aspect of the analysis, the AI assigns a confidence score. This score reflects how certain the AI is about its assessment, based on the clarity of the claim and how closely it aligns with or deviates from known patterns of compliance.
Clause-Specific Analysis
Each claim is analysed against specific clauses of the ABPI, EFPIA, IMC, JPMA, OPPI, PhRMA and RDPAC codes. The AI checks for alignment with each clause's requirements, such as accuracy, balance, substantiation, and appropriate use of language.
Explanation Generation
Based on its analysis, the AI generates a detailed explanation of its findings. This includes identifying potential issues, referencing relevant clauses, and suggesting improvements.
Our Security and Privacy Measures
We prioritise the security of your data. Below are the key security measures we have implemented to protect your information.
ABPI Claims Database
This database includes a range of examples, including:
-
Compliant claims that adhere to the ABPI Code of Practice
-
Non-compliant claims that violate specific Code clauses
-
Borderline cases that illustrate the nuances of Code interpretation
Each example is accompanied by an explanation of its compliance status, relevant ABPI Code clauses, and, where applicable, suggestions for improvement.
While this database serves as a valuable reference, it's important to remember that each promotional claim is unique and context-dependent. Use these examples as a guide, but always rely on the full ABPI Code, our Compliance Checker tool, and expert judgment for your specific case.
Efficacy
"In a randomised controlled trial, Drug A reduced HbA1c levels by an average of 1.2% in patients with type 2 diabetes."
Compliance
This claim is specific, based on clinical data, and doesn't exaggerate
Relevant Clauses
6.1, 6.2
Onset of Action
"In clinical studies, Drug D demonstrated a median time to pain relief of 30 minutes in patients with acute migraine."
Compliance
Provides specific, measurable data about onset of action.
Relevant Clauses
6.1, 6.2
Safety
"The most common side effects of Drug B include headache (10%) and nausea (8%)."
Compliance
Provides balanced information about adverse reactions with specific frequencies
Relevant Clauses
6.1, 6.4
Mechanism of Action
"Drug E is a selective serotonin reuptake inhibitor that increases serotonin levels in the brain"
Compliance
Accurately describes the mechanism without making superiority claims
Relevant Clauses:
6.1
Quality of Life
"Patients treated with Drug C reported a 30% improvement in sleep quality scores compared to baseline"
Compliance
Specific claim based on measurable outcomes without exaggeration
Relevant Clauses
6.1, 6.2
Onset of Action
"In studies, Drug F began to relieve nasal congestion symptoms in allergic rhinitis patients within 30 minutes of administration for the majority of subjects"
Compliance: This claim is specific about the timeframe and doesn't overgeneralise to all patients
Relevant Clauses
6.1, 6.2, 14.2
Disclaimer This Compliance Checker is provided as an informational tool only and should not be considered legal or professional advice. The tool currently analyzes claims against selected clauses of the 2021 ABPI Code of Practice (specifically Clauses 6.1, 6.2, 6.4, 6.5, 6.6, 14.1, 14.2, 14.3, 14.4, and 15.2), Articles 1-9 of the 2019 EFPIA Code, Sections 1-3, 7, 10, and 11 of the PhRMA Code, Sections 1-4 of the JPMA Code, Articles 1-5 of the PAAB Code, Sections 1-8 of the IPHA Code, and the PMCPA Social Media Guidance. While these sections and guidance cover key aspects of promotional compliance, they do not represent the entirety of the ABPI, EFPIA, PhRMA, JPMA, PAAB, IPHA Codes, or PMCPA Social Media Guidance. Users should be aware that the tool's analysis is based on the 2021 version of the ABPI Code, the 2019 version of the EFPIA Code, the current versions of the PhRMA, JPMA, PAAB, and IPHA Codes, and the PMCPA Social Media Guidance, and may not reflect any changes introduced in subsequent updates. While we strive for accuracy, the tool's analysis is based on AI interpretation of these specific clauses, sections, and guidance and may not capture all nuances of the ABPI Code of Practice, the EFPIA Code, the PhRMA Code, the JPMA Code, the PAAB Code, the IPHA Code, or the PMCPA Social Media Guidance, or consider clauses and sections not included in the tool's database. It's important to note that the AI may not capture every nuance that a human expert would. While the tool continues to learn and improve with each use, it should not replace expert human judgment. The results generated by this tool are not a substitute for a thorough review by qualified professionals familiar with the complete and most current ABPI Code, EFPIA Code, PhRMA Code, JPMA Code, PAAB Code, IPHA Code, PMCPA Social Media Guidance, and relevant regulations. Users should always consult the full, up-to-date versions of these Codes and seek expert advice when necessary. The creators of this tool are not responsible for any decisions or actions taken based on the output provided. It is the user's responsibility to ensure compliance with all applicable laws, regulations, and industry codes, including sections of the ABPI Code, EFPIA Code, PhRMA Code, JPMA Code, PAAB Code, IPHA Code, and PMCPA Social Media Guidance not covered by this tool. This tool does not guarantee approval or acceptance by any regulatory body, the ABPI, EFPIA, PhRMA, JPMA, PAAB, IPHA, or PMCPA. Use of this tool does not establish any form of attorney-client relationship or professional consultation. By using this tool, you acknowledge and agree to these limitations and disclaimers, and understand that the tool's analysis is limited to the specified ABPI Code clauses from the 2021 version of the Code, the specified EFPIA Code articles from the 2019 version of the Code, the specified PhRMA Code sections, the specified JPMA Code sections, the specified PAAB Code articles, the specified IPHA Code sections, and the PMCPA Social Media Guidance.
Copyright © 2024 Medcopywriter Limited. All rights reserved.
Company Number 08159703 | VAT Reg GB139785953.